South African Company to Produce Pfizer Vaccine in Africa for First Time 

The Pfizer-BioNTech COVID-19 vaccine will be produced in South Africa for the first time, the company announced Wednesday.

The Cape Town-based Biovac Institute will produce the vaccine for Pfizer starting in 2022, the Associated Press reported. The company will distribute the vaccine throughout Africa.

As cases surge, Africa has struggled to obtain more vaccine doses. Biovac set a goal of creating 100 million doses annually.

Vaccinations in South Africa have increased, with 1.4 million people being fully vaccinated. Over 220,000 people are getting COVID-19 shots on weekdays, per AP. The country hopes that 67% of its population will be vaccinated by February 2022.

RELATED: South Africa starts jabs for elderly as virus surge looms

Latest in News

News

Jelani Day’s Mother Highlights Racial Disparities in Handling of Case

News

Kelly Price’s Lawyer Says Singer Not Missing, Despite Claims From Family

News

Kelly Price Missing Weeks After COVID-19 Diagnosis, Family Says

Police Brutality

News

Three Police Officers Face Felonies in Arrest of Two Black Men in Miami Beach

News

Florida GOP Introduces Texas-Style Abortion Ban Legislation

News

Morgan State University Produces Second Astronaut Scholarship Recipient

YBN Cordae Portrait Session

News

‘Kick it with Cordae’ College Tour Big Hit with Esports Gamers at HBCUs

News

Maryland Church Seeks to Regain Historic Slave Cemetery